Endothelin-1 expression by vascular endothelial growth factor in human umbilical vein endothelial cells and aortic smooth muscle cells

Hypertension in Pregnancy

Volumn 30, Issue 3, 2011, Pages 295-301

  Seol, Hyun Joo ^a   Oh, Min Jeong ^b   Kim, Hai Joong ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Aortic smooth muscle cells; Endothelin 1; Human umbilical vein endothelial cells; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME INHIBITOR; PHOSPHORAMIDON; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN;

ARTICLE; CELL VIABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MUSCLE CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL;

AORTA; ASPARTIC ACID ENDOPEPTIDASES; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GLYCOPEPTIDES; HUMANS; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960152642     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903115053     Document Type: Article

References (18)

1. Gilstrap LC III, Ramin SM. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77:67-75.
2. Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991; 17:1072-1077.
3. Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy- induced hypertension. N Engl J Med 1990; 323:1486-1487. (Pubitemid 20384965)
4. Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008; 294:F1185-F1194.
5. Brockelsby J, Hayman R, Ahmed A, et al. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: Implications in the pathogenesis of preeclampsia. Lab Invest 1999; 79:1101-1111. (Pubitemid 29444540)
6. Brockelsby JC, Anthony FW, Johnson IR, Baker PN. The effects of vascular endothelial growth factor on endothelial cells: A potential role in preeclampsia. Am J Obstet Gynecol 2000; 182:176-183. (Pubitemid 30074389)
7. Svedas E, Islam KB, Nisell H, Kublickiene KR. Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. Am J Obstet Gynecol 2003; 188:168-176. (Pubitemid 36135615)
8. Matsuura A, Kawashima S, Yamochi W, et al. Vascular endothelial growth factor increases endothelin-converting enzyme expression in vascular endothelial cells. Biochem Biophys Res Commun 1997; 235:713-716. (Pubitemid 27326549)
9. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ Res 1998; 83:832-840. (Pubitemid 28489080)
10. Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 1999; 85:906-911. (Pubitemid 29534165)
11. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptideselective subtype of the endothelin receptor. Nature 1990; 348:732-735. (Pubitemid 120015148)
12. Xu D, Emoto N, Giaid A, et al. ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78:473-485. (Pubitemid 24250811)
13. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86:815-821.
14. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658. (Pubitemid 36278583)
15. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683. (Pubitemid 38364626)
16. Anthony FW, Evans PW, Wheeler T, Wood PJ. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 1997; 34(Pt 3):276-280. (Pubitemid 27236931)
17. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001; 47:617-623. (Pubitemid 32275802)
18. Bhattacharjee G, Asplin IR, Wu SM, Gawdi G, Pizzo SV. The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding. J Biol Chem 2000; 275:26806-26811.